Normunity AccelCo, Inc.
1 clinical trials · Sponsor
◉ Watch Normunity AccelCo, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors (NCT07182149) | Normunity AccelCo, Inc. | 2025-10-30 |
Track Normunity AccelCo, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.